SEHK:2367Personal Products
Giant Biogene Holding SEHK 2367 Valuation Check After Weaker Earnings And Adjusted Dividends
Giant Biogene Holding (SEHK:2367) released full year 2025 results, reporting revenue and net income below the prior year. The company also proposed a reduced final ordinary dividend alongside a separate special dividend for shareholders.
See our latest analysis for Giant Biogene Holding.
Despite the latest earnings release and the mix of a reduced ordinary dividend with a separate special dividend, Giant Biogene Holding’s 1-year total shareholder return of 56.34% decline and 3-year total...